EUVIMEDEUVIMED entdecken
Randomisierte kontrollierte StudieOpen Access

Construction of a lncRNA-mediated ceRNA network and a genomic-clinicopathologic nomogram to predict survival for breast cancer patients

Mengni Wu, Linlin Lu, Tiantian Dai, Aoshuang Li, Yue Yu, Yadi Li, Zhihua Xu, Yan Chen

Cancer Biomarkers · 2023

DOI: 10.3233/cbm-210545 ↗

Kurz gefasst

Randomisierte kontrollierte Studie in der Zeitschrift Cancer Biomarkers, 2023. Verfasst von Mengni Wu und 7 weiteren Autor:innen. Hauptthemen laut MEDLINE: Breast Neoplasms, RNA, Long Noncoding, MicroRNAs. Die Arbeit wurde bisher 9-mal zitiert (Crossref) und nennt 41 Literaturangaben. Der Volltext ist frei in PubMed Central verfügbar.

AbstractSchlagwörterBibliografische AngabenZitierenVerwandte Studien

Abstract (Originalsprache)

Breast cancer (BC) is the most common cancer among women and a leading cause of cancer-related deaths worldwide. The diagnosis of early patients and the prognosis of advanced patients have not improved over the past several decades. The purpose of the present study was to identify the lncRNA-related genes based on ceRNA network and construct a credible model for prognosis in BC. Based on The Cancer Genome Atlas (TCGA) database, prognosis-related differently expressed genes (DEGs) and a lncRNA-associated ceRNA regulatory network were obtained in BC. The patients were randomly divided into a training group and a testing group. A ceRNA-related prognostic model as well as a nomogram was constructed for further study. A total of 844 DElncRNAs, 206 DEmiRNAs and 3295 DEmRNAs were extracted in BC, and 12 RNAs (HOTAIR, AC055854.1, ST8SIA6-AS1, AC105999.2, hsa-miR-1258, hsa-miR-7705, hsa-miR-3662, hsa-miR-4501, CCNB1, UHRF1, SPC24 and SHCBP1) among them were recognized for the construction of a prognostic risk model. Patients were then assigned to high-risk and low-risk groups according to the risk score. The Kaplan-Meier (K-M) analysis demonstrated that the high-risk group was closely associated with poor prognosis. The predictive nomogram combined with clinical features showed performance in clinical practice. In a nutshell, our ceRNA-related gene model and the nomogram graph are accurate and reliable tools for predicting prognostic outcomes of BC patients, and may make great contributions to modern precise medicine.

Schlagwörter

MeSH-Schlagwörter (MEDLINE)

Breast NeoplasmsRNA, Long NoncodingMicroRNAsHumansFemaleNomogramsGene Regulatory NetworksPrognosisGenomicsCCAAT-Enhancer-Binding ProteinsUbiquitin-Protein LigasesShc Signaling Adaptor Proteins

Stichwörter der Autor:innen

Breast cancerceRNAnomogramprognosisrisk model

Substanzen

RNA, Long NoncodingMicroRNAsUHRF1 protein, humanCCAAT-Enhancer-Binding ProteinsUbiquitin-Protein LigasesSHCBP1 protein, humanShc Signaling Adaptor ProteinsMIRN1258 microRNA, humanMIRN-3662 microRNA, human

Zitieren

APA

Wu, M., Lu, L., Dai, T., Li, A., Yu, Y., Li, Y., Xu, Z., & Chen, Y. (2023). Construction of a lncRNA-mediated ceRNA network and a genomic-clinicopathologic nomogram to predict survival for breast cancer patients. Cancer Biomarkers. https://doi.org/10.3233/cbm-210545

Vancouver

Wu M, Lu L, Dai T, Li A, Yu Y, Li Y, et al. Construction of a lncRNA-mediated ceRNA network and a genomic-clinicopathologic nomogram to predict survival for breast cancer patients. Cancer Biomarkers. 2023. doi:10.3233/cbm-210545

BibTeX
@article{Wu2023,
  author = {Wu, Mengni and Lu, Linlin and Dai, Tiantian and Li, Aoshuang and Yu, Yue and Li, Yadi and Xu, Zhihua and Chen, Yan},
  title = {Construction of a lncRNA-mediated ceRNA network and a genomic-clinicopathologic nomogram to predict survival for breast cancer patients},
  journal = {Cancer Biomarkers},
  year = {2023},
  doi = {10.3233/cbm-210545}
}
Kostenlos starten →